Gene sequencing giant Illumina Inc. is calling for startups to apply to its business accelerator program for early-stage businesses in the genomics space.

The program, called Illumina Accelerator, provides startups with seed investment, business guidance, and lab space in close proximity to Illumina’s R&D labs.

The accelerator, first launched in 2014, offers entrants partner support, including financial modeling, forecasting, legal, recruiting, licensing, technical expertise, and a go-to-market strategy.

Candidate teams are limited to four members, and must be genomic researchers, entrepreneurs, startups, or early-stage companies from academia or industry that aim to take their promising next generation applications to market.

San Diego-based Illumina is the world’s largest maker of next generation sequencing machines, with a market cap of $22 billion.

Applications for the Illumina Accelerator for this current funding cycle are due September 1, 2016.